The relationship between mammalian facilitative glucose transport proteins (GLUT) and multidrug resistance was examined in two vincristine (VCR)-selected murine erythroleukaemia (MEL) PC4 cell lines. GLUT proteins, GLUT1 and GLUT3, were constitutively coexpressed in the parental cell line and also in the VCR-selected cell lines. Increased expression of the GLUT1 isoform was noted both in the PC-V40 (a non-P-glycoprotein, mrp-overexpressing subline) and in the more resistant PC-V160 (overexpressing mrp and mdr3) cell lines.
Mechanisms associated with the development of MDR are often energy-dependent processes, which involve membrane transport (Juranka et al, 1989; Gottesman, 1993; Gottesman and Pastan, 1993) and detoxification of drugs (Tew, 1994) . This adaptation to MDR may involve additional energy requirements (Haspel et al, 1986; Fanciulli et al, 1993) . For example, alterations in glucose metabolism are associated with drug resistance in tumour cell lines. One characteristic of malignant cells is an increased rate of oxidative glycolysis and a preferential utilization of oxidative phosphorylation to synthesize ATP (Lyon et al, 1988) .
Much of the energy demands are met by glucose transport across the plasma membrane of mammalian cells, mediated by a family of facilitative glucose transporters (GLUT1-4) (Kahn and Flier, 1990; Bell et al, 1993) . These exhibit a tissue-specific pattern of expression and distinct kinetic and regulatory properties (Pessin and Bell, 1992) . The diversity of the isoforms allows for the regulation of intracellular glucose levels over a range of physiological conditions. GLUT1 is abundantly expressed in erythroid cells; GLUT3 is the primary transporter of glucose in neurons (Bell et al, 1990 (Bell et al, , 1993 . GLUT1 and GLUT3 are considered to be responsible for basal glucose transport in mammalian cells and are localized primarily in the plasma membrane (Asano et al, 1992; Pessin and Bell, 1992) . Facilitative glucose transport is an energy-independent saturable process using an alternating conformational model of sugar transport (Walmsley, 1988) .
A possible role for the glucose transporter in the modulation of multidrug resistance (MDR) was suggested (Vera et al, 1991) . These investigators found that glucose transport inhibitors (GTIs) increased VCR accumulation in Xenopus oocytes transfected with GLUTI mRNA. The effect of GTIs on VCR transport in a MDR cell line also suggested a role for GLUT proteins in VCR transport. We examined the effect of GTIs on vincristine transport in drug-resistant MEL cell lines, which coexpressd GLUT1 and to the highest drug concentration (ng ml-') into which they were passaged, have been described previously (Slapak et al, 1994) . The PC-V40 subline was 42-fold more resistant and PC-V160 was 215-fold more resistant to VCR than the parental cell line. Both sublines demonstrated energy-dependent VCR efflux and overexpressed the multidrug resistance-associated protein (MRP) (Slapak et al, 1996) ; only PC-V160 cells overexpressed P-glycoprotein (Slapak et al, 1994) . Another MEL cell line, C7D (Slapak et al, 1990) , and AUXB 1 cells (Maher et al, 1992) , an auxotrophic CHO cell line (provided by V Ling, Ontario Cancer Institute, Toronto, Canada), were used as controls for GLUT I and GLUT3 identification in membrane preparations. Cells were grown in Eagle's basal medium (PC4 and C7D) or minimal essential media (AUXB 1) supplemented with 10% heat-inactivated fetal calf serum in a 5% carbon dioxide atmosphere (Revco 2000, Ashville, NC, USA).
Evaluation of steady-state glucose transport Steady-state glucose transport was measured as a function of the uptake of the glucose analogue 2-deoxy-D-glucose (dGlc) at 50 gM (Asano et al, 1991) in phosphate-buffered saline (PBS) during a 60-min incubation at 37°C. This analogue is not metabolized by mammalian cells beyond the initial phosphorylation step by hexokinase. At this concentration, dGlc presumably represents steadystate glucose levels (Renner et al, 1972) . Cells (1 x 106 ml' were preincubated either in the presence of 100 gM phloretin/PBS or PBS alone for 15 min at 37°C. Prior to an additional 60 min, 50 gM dGlc and 5 gCi ml-' (0.096 JM) 2-deoxy-D-[2,6-3H]glucose (52 Ci mmol-'; Dupont New England Nuclear, Boston, MA, USA) were added. The reactions were terminated by centrifugation (3 min at 10 000 x g) of 200-,ul samples (2 x I05 cells) through silicone oil in microfuge tubes previously prepared with 20 gl of formic acid overlaid with 200 ,ul of silicone oil (D = 1.035-1.045; Nye Lubricants, New Bedford, MA, USA). After freezing the tubes, the tips were severed (containing the frozen formic acid/cell pellet) and the cell-associated radioactivity was determined by scintillation counting (Slapak et al, 1996) . The data are expressed as a percentage of cell-associated [3H]dGlc in parental cells after 60 min of incubation from six experiments each performed in duplicate.
Kinetics of glucose transport Cells were washed extensively in PBS and resuspended to 1 x 106 ml-' in PBS at 37°C. 2-deoxy-D-[2,6-3H] glucose ([3H] dGlc)(52 Ci mmol-'; Dupont New England Nuclear, Boston, MA, USA) was added (1.6 ,uCi ml-') to a final concentration of 0.2-2 mm dGlc. Over a 5-min interval, the uptake of [3H]dGlc increased linearly with time for each subline. Therefore, uptake, and not phosphorylation, was the main determinant in cellular dGlc accumulation (Colville et al, 1993) . Cell-associated radioactivity was determined after centrifugation of samples (2 x 105 cells) through silicone oil (described above) and the cell pellets were quantified for nmol of [3H]dGlc. Km and Vmax values were derived from a linear regression of a Lineweaver-Burk graph.
DNA probes for hybridization The complete cDNA for rat erythroidlbrain hexose transporter, GLUTI, was provided by J Vera (Memorial Sloan Kettering Cancer Research Center, NY, USA). A 1.1-kb probe was generated by digestion with NcoI. Rat GLUT2 (prGLUT2), mouse GLUT3 (pmGLUT3-6), rat GLUT4 (prGLUT4) and rat GLUT5 (prGLUT5-4) probes were derived from glucose transporter cDNA clones kindly supplied by Graeme Bell (Howard Hughes Medical Institute, The University of Chicago, USA) (Bell et al, 1993) . A P-actin DNA probe (V Stanton, MIT, Cambridge, MA, USA) was used to assess RNA loading. All probes were labelled in-gel with a random primer labelling kit (Boerhinger-Mannheim, Indianapolis, IN, USA) to a specific activity of 1-2 x 109 c.p.m. ,ug-' DNA.
RNA extraction and Northern hybridization RNA was prepared by lysis of 1 x 108 logarithmically grown cells with guanidine isothiocyanate and then centrifugation through a caesium chloride cushion (Chirgwin et al, 1979) . The RNA was analysed by electrophoresis through 1% agarose gels after denaturing by treatment with formaldehyde. The RNA was transferred by blotting to Gene-Screen Plus hybridization membranes (New England Nuclear, Boston, MA, USA). Membranes were prehybridized for 4 h and then hybridized overnight at 42°C in 50% formamide, 5 x SSPE 7.5% dextran sulphate, I x Denhardt's solution, 1% sodium dodecyl sulphate (SDS) and 0.2 mg ml-' denatured salmon sperm DNA. The blots were washed to a final stringency of 0.2 x SSPE/0.1% SDS at 56-65°C before exposure to Kodak XAR film at -70°C.
Membrane isolation
Membrane protein fractions from each subline were prepared as previously described (Vera et al, 199 1; Schurmann et al, 1992) with some modifications. Cells (4 x 108) were washed twice in PBS and resuspended into 5 ml of lysis buffer (20 mm Tris-Cl, pH 7.4, 1 mm EDTA, 230 mm sucrose containing 20 ,ig ml-' aprotinin, 20 ,ug ml-' leupeptin, 50 ,ug ml-' soybean trypsin inhibitor and 1 mM phenylsulphonylfluoride) and homogenized on ice with a Dounce homogenizer. The homogenates were centrifuged at 1500 x g for 10 min at 4°C to pellet the nuclei. For total membranes, the resultant supernatant was centrifuged at 150 000 x g for 90 min at 4°C to yield a total membrane fraction, resuspended in lysis buffer and stored at -70°C. For plasma membrane-enriched fraction, the supernatant was centrifuged at 16 000 x g for 15 min at 4°C. The resulting pellets were resuspended in lysis buffer, layered onto a 1.12 M sucrose cushion (refractive index 1.3902, 38% w/v) and centrifuged for 70 min at 100 000 x g at 4°C. Plasma membranes were collected from the interface between buffer and sucrose, resuspended in lysis buffer and stored at -70°C. Plasma membrane protein was quantified by assaying the relative activity of alkaline phosphodiesterase I using sodium thymidine 5 '-monophosphate, pnitrophenyl ester (Sigma, St Louis, MO, USA) (Draye et al, 1987) .
Analysis of GLUT1 and GLUT3 expression by Western blotting
Plasma membrane protein samples were quantified using lysozyme as a standard, reduced in Laemmli's buffer without boiling (Asano et al, 1989) and resolved by electrophoresis (5 and 1 ,ug per lane) on an 11% SDS-polyacrylamide minigel (Laemmli, 1970) . After electrophoresis, the gels were washed in Towbin's transfer buffer (25 mM Tris, 192 mm glycine) with 20% methanol with 0.01% SDS. Samples were electroblotted overnight (30 V, 100 mA) at 4°C to PVDF membranes (Immobolin P, 0.45 gM pore size; Millipore, Bedford, MA, USA). The membranes were blocked in TBST [20 mm Tris, pH 7.6, 1% bovine serum albumin (BSA) (w/v), 150 mm sodium chloride, 0.05% Tween-20] for 1 h at 25°C.
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After three washes in TBST, the membranes were probed with an affinity-purified polyclonal antibody (East Acres Biologicals, Southbridge, MA, USA) to the carboxy terminus of GLUT1 (Haspel et al, 1988) or GLUT3 (Nagamatsu et al, 1992 ) at a dilution of 1:5000 in TBST for 2 h at 25°C. After three washes in TBST, the immunocomplexes were detected using ['251 ]protein A at 0.01 gCi ml-'; (117 mCi mg-' ICN) for 1 h at 25°C, washed in TBST and air dried. Autoradiograms were analysed after exposure to Kodak XAR film at -70°C and/or storage phosphor technology (Phosphorlmager, Molecular Dynamics, Sunnyvale, CA, USA). Molecular weight standards were electroblotted with samples.
Quantification of GLUT1 and GLUT3 in the plasma membrane by immunodot blots Plasma membrane protein samples were processed to Immobolin P membranes pre-equilibrated in Towbin's buffer using a minifold dot blot apparatus (Schleicher & Schuell, Keene, NH, USA).
Immobolin P (0.45-gM pore size) was determined by Western blot analysis to retain a maximum of 2.5 ,ug of MEL plasma membrane protein. Duplicate plasma membrane samples (serial dilutions from 0 to 2.5 gg) were adsorbed by dot blot to PVDF filter membranes and washed in TE (pH 7.4). After Western blotting, the immunocomplexes were detected with a 1:5000 dilution of GLUTI or GLUT3 antisera as described above. The dot blots were quantified by volume integration of pixels/standard dot blot area using storage phosphor technology (Molecular Dynamics, Sunnyvale, CA, USA) (Johnston et al, 1990 ) and recorded as pixels jg-protein for each cell line. The relative level of expression for each isoform (GLUTI or GLUT3) was normalized to the parental cell line.
Vincristine steady-state accumulation studies VCR accumulation was assayed in 106 cells ml-' after 60 min incubation in PBS using 25 nm [G-3H] The concentration of CB used in these experiments was specific for glucose transport inhibition and minimized other non-glucose transport affinity binding and actin binding (Rampal et al, 1980) . CE has a low binding affinity for glucose transport proteins and was used as a control to demonstrate a specific glucose transporter binding by cytochalasin B (Vera et al, 1991) . There was no solvent effect on cell viability or VCR uptake with dimethyl sulphoxide (DMSO) (0.08%, CB and CE).
Effect of phloretin on vincristine efflux
Approximately equimolar intracellular concentrations of VCR were achieved in each subline (PC4-WT, PC-V40 and PC-V160) at 1 x 106 cells ml-' in PBS by adding [G-3H] vincristine sulphate (25 nM, 50 nm and 100 nm respectively during a 60 min incubation in a 37°C shaking water bath. Cells were collected by centrifugation and resuspended to 1 x 106 cells ml-' in drug-free PBS at 37°C. At time zero, phloretin was added to a final concentration of 50 gM. Cells were incubated for 5 min at 37°C; VCR efflux has been demonstrated to be linear for at least 5 min (Slapak et al, 1996) . Residual cell-associated radioactivity was determined after centrifugation through silicone oil as described above. There was no solvent effect (0.2% ethanol) on VCR efflux.
Intracellular ATP levels
Cells were washed directly out of growth media. Employing a luminescence determination (Bioluminescent Somatic Cell Assay Kit, Sigma), duplicate tests with 5 x 104 cells were assayed and light emission was measured by use of a liquid scintillation spectrophotometer (Beckman LS-235, Fullerton, CA, USA) (Stanley and Williams, 1969) .
Method for sequence comparisons
The translation of human MRP (GenBank/EMBL accession no. L05628) (Cole et al, 1992) , mouse MRP (amino acids 601-799; R Deeley, personal communication), mouse GLUTI (GenBank/EMBL accession no. M23384) (Kaestner et al, 1989) and mouse GLUT3 (GenBank/EMBL accession no. M75135) (Haspel et al, 1988) sequences were analysed using the program Gap from the Sequence Analysis Software Package of the Genetics Computer Group (University Research Park, Madison, WI, USA) (Needleman and Wunsch, 1970) . A gap weight of 5.0 and length weight of 0.3 were used in the analyses.
Protein secondary structure predictions of the proposed cytochalasin B binding site in human MRP (amino acids 686-710) (Cole et al, 1992) , mouse GLUTI (amino acids 388-412) (Kaestner et al, 1989) and mouse GLUT3 (amino acids 386-410) (Haspel et al, 1988) were performed using the MacVector program. Hydropathy plots were graphed using the Kyte-Doolittle scale and a window of seven amino acids (Kyte and Doolittle, 1982 line (Figure 1 ). The transport of glucose was inhibited approximately 85-90% (P<0.05) by the competitive glucose transport inhibitor, phloretin (100 gM) (Figure 1 ). As a competitive inhibitor of glucose transport, the effect of phloretin differentiated facilitative glucose transport from simple hexose diffusion (Krupka and Deves, 1980; Wheeler and Hinkle, 1985) . These findings suggested that dGlc, and therefore glucose, uptake occurred primarily via a facilitative glucose transporter(s) in the PC4 sublines.
Kinetic analysis of glucose transport The kinetics of glucose transport were evaluated in the sublines (Table 1 and Figure 2 ). Increases in V were observed: 1.9-fold increase in PC-V40 and a 2.5-fold increase in the PC-V160 cell line. The high correlation coefficients (r) calculated from the linear regression of the glucose transport studies suggested unidirectional glucose transport into the cells (Asano et al, 1989;  A PC4-WT (Asano et al, 1991 (Asano et al, , 1992 and for the mammalian brain glucose transporter, GLUT3 (Asano et al, 1992; Bell et al, 1993) .
Analysis of GLUT expression by Northern hybridization
Total RNA from each subline was examined by Northern analysis with rodent-specific cDNA probes for the GLUTI-5 transcripts.
Under high-stringency hybridization conditions, expression of both GLUT1 and GLUT3 was detected in the parental and VCRselected sublines ( Figure 3A) . Expression of GLUT2, GLUT4 and GLUT5 was not detected even with prolonged film exposure. The mRNA transcripts of GLUT1 and GLUT3 were approximately 2.8 kb. The GLUT3 hybridized to a smaller transcript (2.8 kb) in these erythroid cells than the size (4.0 kb) reported previously for neuronal cells (Maher et al, 1992) ; however, a 2.7-kb transcript has been noted in non-neuronal tissues (Yano et al, 1991) . The level of total GLUT mRNA in the parental cell line was reproducible at a higher level than in the more resistant cell lines. Reprobing with the 0-actin probe demonstrated near equal RNA sample loading.
Analysis of GLUTI and GLUT3 protein expression
The level of GLUT protein found in total cell membranes mirrored the pattern of GLUTI and GLUT3 RNA expression: somewhat less protein was seen in the membranes from the PC-V40 and PC-V160 sublines (data not shown). However, this pattern was not seen in the Western blot analyses of the plasma membrane proteinenriched preparations ( Figure 3B) expression was 40% higher in the plasma membranes from the PC-V40 subline and threefold higher in those from the PC-V160 subline ( Figure 3C ). There was little change in the level of GLUT3 protein expression in the PC-V40 cells, but a threefold increase in the PC-V160 cells ( Figure 3C ). These findings paralleled the relative increase in Vmax (Table 1) for glucose uptake in these sublines. The equal activity of alkaline phosphodiesterase I, a plasma membrane-associated enzyme, confirmed equal amounts of the protein samples being tested. AUXB1, a Chinese hamster ovarian cell line, a previously reported (Maher et al, 1992 ) GLUT1-expressing, GLUT3-nonexpressing cell line provided positive and negative controls for the antisera. Another separately derived MEL cell line, C7D (Slapak et al, 1990) , also demonstrated coexpression of GLUT1 and GLUT3 with protein sizes equal to those seen in the PC4-WT cell line (data not shown).
WT V40 V160
Effect of glucose transport inhibitors on vincristine accumulation Compared with the PC4-WT cells, the VCR accumulation in PBS alone was reduced by 41% (P<0.05) in the PC-V40 subline and 79% (P<0.05) in PC-V160 subline (Figure 4) . These findings were similar to the previous studies in the presence of glucose (Slapak et al, 1996) . Pretreatment and incubation of the cell lines in 6 gM cytochalasin B (CB), a competitive glucose transport inhibitor (Deves and Krupka, 1978; Wheeler and Hinkle, 1985; Holman and Rees, 1987; Garcia et al, 1992) , increased the steady-state VCR accumulation in the PC-V40 cell line to the level of PC4-WT cells (P<0.05) (Figure 4) . In contrast, 6 gM cytochalasin E (CE), used to assess any effects of cytochalasin independent of the glucose transport inhibition, did not cause a statistically significant hybridized with 32P-labelled cDNA probes for rat GLUT1, rat GLUT2, mouse GLUT3, rat GLUT4 and rat GLUT5. A hybridization signal (corresponding to a 2.8-kb transcript) was detected only with the GLUT1 and GLUT3 probe.
Rehybridization with cDNA for 3-actin confirmed near-equal loading of lanes. [3H]VCR (25 nM) was added and cells were incubated for an additional 60 min at 370C.
[3H]VCR uptake was determined as described in Figure 1 . were washed out of drug and resuspended in PBS with 50 gM phloretin. After 5 min of incubation at 370C, the reaction was terminated by centrifugation through silicone oil and cell-associated radioactivity was determined as described in Figure 1 Increased vincristine efflux has been demonstrated in PC-V40 and PC-V160 cells; efflux was linear for the first 5 min (Slapak et al, 1996) . VCR efflux was evaluated in the presence of phloretin (PHL). PHL diminished the VCR efflux rate in the PC-V40 subline to nearly that of the PC4-WT subline control (P<0.05) ( Table 2 ). This inhibitor had no significant effect on VCR efflux in PC4-WT or PC-V 160 cells.
Analysis of intracellular ATP content
ATP levels in cells grown in media was 4.1 x 10-'1 mol per cell + 0.90 (s.e.). There was no change in ATP content in the cell lines after a total of 75 min incubation in either CB (6 tM)/PBS or CE (6 JM)/PBS during steady-state VCR accumulation studies.
Sequence comparisons of the MRP, GLUT1 and GLUT3 proteins -SLLSALLAEMDKVEGHV LKGSVAY -710 MRP The gene sequences of human MRP (Cole et al, 1992) , mouse (Figure ) .
contain the putative CB-binding sites within the glucose transporters
Other related gene sequences (Szczypka et al, 1994) were and Rees, 1987; Garcia et al, 1992) . The motif AxLxxxxxxxxxxxxxG aligned to the putative CB-binding domains on GLUT1 and amino acid) was found within the mouse MRP (R Deeley, personal iication), human MRP (Cole et al, 1992) , mouse GLUT1 (Kaestner et GLUT3 using Gap: (1) mouse CFTR; (2) mouse P-glycoprotein ),mouse GLUT3 (Nagamatsu et al, 1992) and mouse GLUT4 (mdrl but not mdr3); (4) Leishmania P-gpA; (5) (Rampal et al, 1980; Vera et al, 1991) . hydrophilic region ( Figure 5B ).
British Journal of Cancer (1997) 75 (2) (Kahn and Flier, 1990; Pessin and Bell, 1992; Bell et al, 1993) and was expected in this murine erythroleukaemia cell line. Not expected was the presence of the mouse GLUT3 isoform. These findings indicated a less restricted tissue distribution for the GLUT3 isoform than has previously been reported (Gould et al, 1992) and represented a novel murine (non-neuronal) GLUT3 tissue expression. The GLUT1 and GLUT3 isoforms are primarily translocated and expressed at the plasma membrane and regulate basal glucose metabolism (Asano et al, 1992; Pessin and Bell, 1992; Schurmann et al, 1992) . The levels of GLUT1 and GLUT3 protein in the total membrane of the cell lines correlated with the relative GLUT1 and GLUT3 mRNA expression (Figure 4 ), but these levels did not correlate with glucose transport. The PC-V40 expressed both a reduced level of mRNA and total protein, but showed increased glucose transport. This discrepancy was clarified by Western blot analysis of the plasma membrane. There, the level of GLUT and GLUT3 proteins correspondingly increased with the level of glucose transport verifying the important location of the glucose transporters.
The discordance between mRNA and protein levels and glucose transport in the PC-V40 cell line may be caused by alterations in metabolic state, in the stability or translatability of the mRNA or the stability of the protein (Yamada et al, 1983; Haspel et al, 1986) and could reflect an adaptive response to an increased energy requirement associated with expression of mrp (PC-V40 subline) or mdr3 (PC-V160 subline). In multidrug-resistant MEL cells, the increased levels of glucose transport protein in the plasma membrane paralleled the increased rates of vincristine efflux and VCR resistance.
The possible participation of GLUTI in drug resistance was previously suggested (Vera et al, 1991) . CB and PHL, two inhibitors of glucose transport, could overcome the reduced Vinca alkaloid, vinblastine, accumulation conferred by the expression of rat GLUT1 in Xenopus oocytes. In their drug-selected MDR cell line expressing mdrl (the level of MRP was not evaluated in these cell lines), CB was able to inhibit the outward transport of vinblastine. However, in transfected oocytes expressing P-gp, this GTI effect was not demonstrated.
In vincristine-selected PC4 cell lines, murine MRP was expressed primarily in the plasma membrane (Slapak et al, 1996 (Draper et al, submitted) . Taken together these data suggest that VCR efflux was primarily associated with MRP overexpression in the PC-V40 cell line and with P-glycoprotein overexpression in the PC-V 160 cell line.
CB has been demonstrated to inhibit glucose transport competitively in erythrocytes (Deves and Krupka, 1978) . It may bind at or near the inward-facing glucose-binding site of GLUTI in the region of Trp-388 to Trp-412 within the transmembrane segment 10-1 l (Garcia et al, 1992) . The amino acid sequences representing the putative CB-binding domain in the GLUT 1 and GLUT3 proteins were compared with the protein sequence of the MRP protein (Cole et al, 1992) . A single polypeptide sequence located between the Walker A and B motifs within the putative N-terminal ATP-binding cassette domain of human MRP showed similarity to the CB-binding site located within the transmembrane 10-11 segments of the GLUT1 and GLUT3 proteins (Figure 5 legend) . The similar hydropathy patterns in these regions suggested possible structural similarities in this sequence among these proteins ( Figure 5 ). The binding domain of phloretin on glucose transport proteins is not well characterized (Krupka and Deves, 1980; Wheeler and Hinkle, 1985) .
The results suggest that CB and PHL block a putative VCR efflux protein, e.g. MRP, or act directly on one or both GLUT proteins, which themselves are somehow associated with drug efflux. It is possible that glucose transporters could in some manner modulate MRP's ability to transport VCR out of the cell. That energy reserves (ATP) were not depleted during the transport inhibition studies indicated that intracellular energy depletion was not responsible for the GTI's effect on VCR efflux in PC-V40 cells. Understanding the mode of action of GTIs on MRP-mediated resistance may help us understand MRP function better, as well as the possible role of GLUT proteins in MRP activity. ABBREVIATIONS MRP, multidrug resistance-associated protein; P-gp, P-glycoprotein; GLUT 1, type 1 isoform of the facilitative glucose transporter; GLUT3, type 3 isoform of the facilitative glucose transporter; VCR, vincristine; MDR, multidrug resistance; dGlc, 2-deoxy-Dglucose; PBS, phosphate-buffered saline; PHL, phloretin; CB, cytochalasin B; CE, cytochalasin E.
